Status:
ENROLLING_BY_INVITATION
Local and Systemic Changes in Osteonecrosis of the Jawbone
Lead Sponsor:
Medical University of Graz
Conditions:
Osteonecrosis of the Jaw
Eligibility:
All Genders
18+ years
Brief Summary
Osteonecrosis of the Jawbone (ONJ) is a serious complication of antiresorptive therapies (ARTs), for example with bisphosphonates or Denosumab. Especially long term treatment with intravenous antireso...
Eligibility Criteria
Inclusion
- 18 years or older
- with/without ART
- with/without MRONJ
Exclusion
- smoker (\>10 cigarettes/day)
- pregnancy
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05329558
Start Date
March 1 2018
End Date
December 1 2026
Last Update
April 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Austria, 8036